牛叉诊股

[{"date":"2026.11.11","stock":"-1.34","trade":"-0.53","ind":"1.32"},{"date":"2026.11.10","stock":"-1.17","trade":"0.88","ind":"0.86"},{"date":"2026.11.09","stock":"-1.00","trade":"-0.20","ind":"-0.27"},{"date":"2026.11.06","stock":"0.08","trade":"-0.80","ind":"-2.57"},{"date":"2026.11.05","stock":"1.01","trade":"1.29","ind":"1.19"},{"date":"2026.11.04","stock":"-0.77","trade":"0.85","ind":"4.22"},{"date":"2026.11.03","stock":"1.21","trade":"0.44","ind":"-1.21"},{"date":"2026.11.02","stock":"1.11","trade":"1.93","ind":"1.63"},{"date":"2026.10.30","stock":"1.49","trade":"-0.03","ind":"-2.73"},{"date":"2026.10.29","stock":"0.00","trade":"-1.62","ind":"-2.92"},{"date":"2026.10.28","stock":"0.16","trade":"0.86","ind":"2.02"},{"date":"2026.10.27","stock":"-0.72","trade":"-2.32","ind":"-2.50"},{"date":"2026.10.26","stock":"1.09","trade":"0.48","ind":"-1.19"},{"date":"2026.10.23","stock":"-0.88","trade":"0.88","ind":"2.79"},{"date":"2026.10.22","stock":"-2.11","trade":"-2.52","ind":"-2.96"},{"date":"2026.10.21","stock":"-1.05","trade":"-0.15","ind":"-0.82"},{"date":"2026.10.20","stock":"-1.71","trade":"-0.28","ind":"-0.14"},{"date":"2026.10.19","stock":"2.70","trade":"0.26","ind":"0.13"},{"date":"2026.10.16","stock":"0.24","trade":"-0.12","ind":"-0.12"},{"date":"2026.10.15","stock":"0.00","trade":"-1.40","ind":"-2.43"},{"date":"2026.10.14","stock":"2.98","trade":"-0.46","ind":"-1.97"}]

华润三九,深证成指,中药指数

压力支撑

该股压力位为25.12元，支撑位为24.79元。

[{"text":"\u538b\u529b\u4f4d","value":"25.12","date":1794326400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"24.79","date":1794326400,"color":"0x0b52a1"}]

多空趋势

多头行情中，上涨趋势有所减缓，可适量做高抛低吸。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.8资金面打败了53%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力集中了一定的筹码，呈中度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：11月11日 20:30

机构今日流向(万元)	-1897.82	机构5日流向(万元)	-4279.10
机构10日流向(万元)	-1689.80	机构20日流向(万元)	-5436.66

机构持仓

2026-06-30 与 2025-12-31 相比，主力机构持仓量减少5434.77万股，其中基金净减仓112家，主力净增仓21家，暂未发现中长期投资价值。

截止2026-06-30，共492家主力机构（基金487家，一般法人2家，QFII1家，保险公司2家），持仓量总计118793.7万股，占流通A股71.45%
其中，基金持仓与2025-12-31相比：
增仓：97家，增持 1275.06万股
减仓：209家，减持 3489.00万股
新出现在主力名单中：146家，持有2983.42万股
从主力名单中消失：125家，原持有5928.62万股

消息面诊股

诊断结果：6.1消息面打败了87%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	临时股东大会	2026-09-02
利好	分红转增	10派4.15元(含税)	2026-08-22
一般消息	重大事项	关联交易	2026-08-22
一般消息	高管变动	由于退休原因	2026-07-15
利好	重大事项	参股拟上市公司或非上市公司金融机构	2026-06-30
一般消息	重大事项	关联交易	2026-04-17
利好	分红转增	10派5.9元(含税)	2026-03-21
一般消息	高管变动	因工作安排原因	2026-01-05
一般消息	重大事项	关联交易	2025-12-31
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-12-31
一般消息	重大事项	关联交易	2025-12-27
一般消息	高管变动	取消监事会	2025-12-26
一般消息	重大事项	关联交易	2025-12-10

一年消息统计

	所有消息	重大消息	非重大消息
利好	4条	0条	4条
利空	0条	0条	0条

行业面诊股

诊断结果：7.7行业面打败了87%的股票中药行业最新资金流向

近10日来该行业走势不明显，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑赢大盘。

[{"date":"2026.11.11","price":"1.32","value":"-0.53"},{"date":"2026.11.10","price":"0.86","value":"0.88"},{"date":"2026.11.09","price":"-0.27","value":"-0.20"},{"date":"2026.11.06","price":"-2.57","value":"-0.80"},{"date":"2026.11.05","price":"1.19","value":"1.29"},{"date":"2026.11.04","price":"4.22","value":"0.85"},{"date":"2026.11.03","price":"-1.21","value":"0.44"},{"date":"2026.11.02","price":"1.63","value":"1.93"},{"date":"2026.10.30","price":"-2.73","value":"-0.03"},{"date":"2026.10.29","price":"-2.92","value":"-1.62"},{"date":"2026.10.28","price":"2.02","value":"0.86"},{"date":"2026.10.27","price":"-2.50","value":"-2.32"},{"date":"2026.10.26","price":"-1.19","value":"0.48"},{"date":"2026.10.23","price":"2.79","value":"0.88"},{"date":"2026.10.22","price":"-2.96","value":"-2.52"},{"date":"2026.10.21","price":"-0.82","value":"-0.15"},{"date":"2026.10.20","price":"-0.14","value":"-0.28"},{"date":"2026.10.19","price":"0.13","value":"0.26"},{"date":"2026.10.16","price":"-0.12","value":"-0.12"},{"date":"2026.10.15","price":"-2.43","value":"-1.40"},{"date":"2026.10.14","price":"-1.97","value":"-0.46"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	桂林三金	25.92%	-10.91%	6.7分
2	*ST香雪	21.41%	45.98%	6.2分
3	维康药业	21.24%	22.80%	6.4分
4	恩威医药	10.21%	1.40%	5.9分
5	达仁堂	8.92%	-5.79%	5.3分
6	片仔癀	7.82%	-1.46%	6.0分
7	羚锐制药	6.72%	-3.51%	6.9分
8	济川药业	6.65%	2.32%	6.9分
9	盘龙药业	5.78%	7.36%	5.6分
10	步长制药	5.10%	-1.40%	6.2分
11	葵花药业	3.68%	-1.99%	5.8分
12	以岭药业	3.58%	-2.74%	5.9分
13	信邦制药	3.45%	-3.23%	6.6分
14	云南白药	3.13%	-1.27%	6.4分
15	健民集团	3.00%	-1.66%	6.3分
16	昆药集团	2.24%	-0.46%	5.5分
17	新光药业	1.32%	1.46%	4.6分
18	东阿阿胶	1.31%	-2.84%	6.3分
19	亚宝药业	0.87%	-1.42%	5.1分
20	天士力	-0.43%	-2.51%	6.0分
21	康缘药业	-0.72%	-3.44%	6.0分
22	同仁堂	-1.30%	-3.57%	4.9分
23	吉林敖东	-1.45%	-2.19%	5.4分
24	康美药业	-1.50%	-5.76%	5.4分
25	-	-1.53%	5.88%	分
26	马应龙	-1.59%	-2.81%	6.0分
27	华润三九	-1.80%	-2.42%	6.4分
28	方盛制药	-2.32%	-1.84%	5.1分
29	华润江中	-2.37%	-2.66%	6.6分
30	奇正藏药	-2.52%	-2.31%	5.8分
31	白云山	-2.74%	-3.27%	5.2分
32	三力制药	-2.85%	-0.27%	5.0分
33	ST百灵	-2.86%	-0.90%	4.3分
34	红日药业	-3.08%	-2.48%	5.1分
35	仁和药业	-3.45%	-2.14%	5.3分
36	ST嘉应	-3.78%	4.09%	5.6分
37	ST葫芦娃	-3.90%	3.04%	5.5分
38	陇神戎发	-3.98%	9.80%	5.6分
39	珍宝岛	-4.03%	1.21%	5.6分
40	振东制药	-4.13%	1.46%	5.7分
41	九芝堂	-4.22%	-0.47%	6.7分
42	康恩贝	-4.34%	-4.12%	5.9分
43	华森制药	-4.66%	2.58%	6.0分
44	寿仙谷	-5.10%	0.29%	5.0分
45	太极集团	-5.69%	-0.78%	5.9分
46	-	-6.11%	1.07%	分
47	千金药业	-6.13%	-0.83%	6.5分
48	上海凯宝	-6.25%	-1.64%	5.4分
49	佐力药业	-6.38%	-1.91%	5.1分
50	特一药业	-6.59%	0.11%	5.2分
51	众生药业	-6.63%	3.19%	6.1分
52	汉森制药	-6.88%	2.05%	6.2分
53	佛慈制药	-6.92%	-1.57%	6.1分
54	新天药业	-7.29%	1.33%	5.6分
55	ST金花	-7.89%	-0.50%	5.2分
56	中恒集团	-8.87%	3.20%	4.9分
57	太龙药业	-9.02%	-1.06%	4.9分
58	益佰制药	-9.09%	-0.93%	4.7分
59	精华制药	-9.60%	-0.42%	5.5分
60	沃华医药	-10.16%	-0.66%	6.6分
61	广誉远	-10.72%	-3.70%	4.8分
62	益盛药业	-11.24%	0.66%	5.3分
63	古汉医药	-11.52%	1.28%	4.7分
64	康惠股份	-12.46%	4.00%	5.4分
65	华神科技	-12.98%	1.97%	5.3分
66	粤万年青	-15.28%	6.97%	4.7分
67	ST万邦	-15.99%	7.33%	5.3分
68	天目药业	-23.37%	2.23%	5.2分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：7.2基本面打败了91%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：强（100分）

基本面得分最高的股票

[ 截止日期：2026-09-30 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 13/110 ， 32/110。

[{"date":"2026-09-30","value":"9.63","vol":"4.23"},{"date":"2026-06-30","value":"7.43","vol":"3.25"},{"date":"2026-03-31","value":"4.74","vol":"2.21"},{"date":"2025-12-31","value":"16.26","vol":"-2.33"},{"date":"2025-09-30","value":"11.47","vol":"4.80"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
净资产收益率(%)	9.63	7.43	4.74	16.26	11.47
行业(%)	4.23	3.25	2.21	-2.33	4.80

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"56.01","vol":"52.92"},{"date":"2026-06-30","value":"56.79","vol":"53.70"},{"date":"2026-03-31","value":"57.68","vol":"55.05"},{"date":"2025-12-31","value":"54.03","vol":"52.85"},{"date":"2025-09-30","value":"53.52","vol":"53.29"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
销售毛利率(%)	56.01	56.79	57.68	54.03	53.52
行业(%)	52.92	53.70	55.05	52.85	53.29

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 23/110 ， 37/110。

[{"date":"2026-09-30","value":"-2.62","vol":"-8.01"},{"date":"2026-06-30","value":"1.37","vol":"-9.08"},{"date":"2026-03-31","value":"18.62","vol":"-5.58"},{"date":"2025-12-31","value":"14.43","vol":"-6.76"},{"date":"2025-09-30","value":"11.38","vol":"-7.84"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
营业收入同比增长率(%)	-2.62	1.37	18.62	14.43	11.38
行业(%)	-8.01	-9.08	-5.58	-6.76	-7.84

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"-8.30","vol":"-22.29"},{"date":"2026-06-30","value":"-7.96","vol":"-101.51"},{"date":"2026-03-31","value":"-15.29","vol":"1.06"},{"date":"2025-12-31","value":"1.58","vol":"-80.25"},{"date":"2025-09-30","value":"-20.51","vol":"-2.78"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
净利润同比增长率(%)	-8.30	-7.96	-15.29	1.58	-20.51
行业(%)	-22.29	-101.51	1.06	-80.25	-2.78

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 24/110 ， 36/110。

[{"date":"2026-09-30","value":"0.37","vol":"0.33"},{"date":"2026-06-30","value":"0.26","vol":"0.22"},{"date":"2026-03-31","value":"0.14","vol":"0.12"},{"date":"2025-12-31","value":"0.64","vol":"0.47"},{"date":"2025-09-30","value":"0.46","vol":"0.35"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
总资产周转率(次)	0.37	0.26	0.14	0.64	0.46
行业(次)	0.33	0.22	0.12	0.47	0.35

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"1.49","vol":"1.72"},{"date":"2026-06-30","value":"1.05","vol":"1.14"},{"date":"2026-03-31","value":"0.56","vol":"0.59"},{"date":"2025-12-31","value":"2.60","vol":"2.34"},{"date":"2025-09-30","value":"1.81","vol":"1.72"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
存货增长率(次)	1.49	1.05	0.56	2.60	1.81
行业(次)	1.72	1.14	0.59	2.34	1.72

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-09-30","value":"-1.96","vol":"13.37"},{"date":"2026-06-30","value":"19.85","vol":"20.65"},{"date":"2026-03-31","value":"12.99","vol":"5.83"},{"date":"2025-12-31","value":"26.91","vol":"30.77"},{"date":"2025-09-30","value":"0.91","vol":"10.53"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
现金流量净额/营业收入	-1.96	19.85	12.99	26.91	0.91
行业	13.37	20.65	5.83	30.77	10.53

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"0.66","vol":"0.88"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.89","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
资本支出／折旧和摊销	-	0.66	-	0.89	-
行业	0.00	0.88	0.00	1.00	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 1/110 ， 25/110。

[{"date":"2026-09-30","value":"2.04","vol":"3.18"},{"date":"2026-06-30","value":"2.02","vol":"3.10"},{"date":"2026-03-31","value":"2.03","vol":"2.97"},{"date":"2025-12-31","value":"1.83","vol":"2.94"},{"date":"2025-09-30","value":"1.83","vol":"3.09"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
流动比率	2.04	2.02	2.03	1.83	1.83
行业	3.18	3.10	2.97	2.94	3.09

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"1.41","vol":"2.39"},{"date":"2026-06-30","value":"1.39","vol":"2.34"},{"date":"2026-03-31","value":"1.36","vol":"2.23"},{"date":"2025-12-31","value":"1.26","vol":"2.15"},{"date":"2025-09-30","value":"1.30","vol":"2.24"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
速动比率	1.41	1.39	1.36	1.26	1.30
行业	2.39	2.34	2.23	2.15	2.24

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 21/110 ， 14/110。

[{"date":"2026-09-30","value":"30.07","vol":"31.42"},{"date":"2026-06-30","value":"29.92","vol":"32.07"},{"date":"2026-03-31","value":"31.76","vol":"31.94"},{"date":"2025-12-31","value":"34.58","vol":"32.43"},{"date":"2025-09-30","value":"33.92","vol":"31.59"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
资产负债率(%)	30.07	29.92	31.76	34.58	33.92
行业(%)	31.42	32.07	31.94	32.43	31.59

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"0.74","vol":"0.67"},{"date":"2026-06-30","value":"0.73","vol":"0.68"},{"date":"2026-03-31","value":"0.79","vol":"0.66"},{"date":"2025-12-31","value":"0.92","vol":"0.67"},{"date":"2025-09-30","value":"0.91","vol":"0.76"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
产权比率 (%)	0.74	0.73	0.79	0.92	0.91
行业(%)	0.67	0.68	0.66	0.67	0.76

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
中信建投证券	2026-11-08	买入	买入
兴业证券	2026-11-03	增持
华创证券	2026-10-29	增持
万联证券	2026-10-28	买入
华泰证券	2026-10-27	增持	增持
国金证券	2026-10-24	买入	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"24.49","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"28.53","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"33.68","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"34.21","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"34.13","blueLineValue":"2.05","type":"YC"}]

[华润三九]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]